The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study of nab-paclitaxel + durvalumab + neoantigen vaccine versus nab-paclitaxel + durvalumab in metastatic triple-negative breast cancer (mTNBC).
 
Leonel Fernando Hernandez-Aya
Consulting or Advisory Role - Massive Bio
Speakers' Bureau - Sanofi/Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Immunocore (Inst); MedImmune (Inst); Merck (Inst); Merck Serono (Inst); Polynoma (Inst); Regeneron (Inst); Roche/Genentech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Sanofi/Regeneron
 
Feng Gao
No Relationships to Disclose
 
Peter S. Goedegebuure
No Relationships to Disclose
 
Cynthia X. Ma
Consulting or Advisory Role - AstraZeneca; Biovica; Lilly; Merck; Novartis; Pfizer; Pfizer; Puma Biotechnology; Syndax; Tempus
Research Funding - Eisai (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Novartis; pfizer; Syndax
 
Foluso Olabisi Ademuyiwa
Honoraria - Advance Medical; Best Doctors, Inc; Cardinal Health
Consulting or Advisory Role - AstraZeneca; Eisai; Immunomedics; Jounce Therapeutics
Research Funding - Abbvie (Inst); Immunomedics (Inst); NeoImmuneTech (Inst); Pfizer (Inst); Polyphor (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Eisai; Immunomedics; Jounce Therapeutics; Odonate Therapeutics
 
Haeseong Park
Research Funding - Ambrx (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Regeneron (Inst); Roche (Inst); Taiho Pharmaceutical (Inst); Vertex (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Bayer
 
Lindsay Leuthen Peterson
No Relationships to Disclose
 
Nusayba Ali Bagegni
No Relationships to Disclose
 
Ron Bose
Honoraria - Foundation Medicine; Genentech
Consulting or Advisory Role - Genentech
Research Funding - Puma Biotechnology (Inst)
 
William E. Gillanders
Research Funding - Genentech/Roche (Inst); MedImmune (Inst)